• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 1.74%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    51.93 Down 0.11(0.21%) 2:39PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:52.04
    Open:52.89
    Bid:52.01 x 200
    Ask:52.04 x 100
    1y Target Est:84.80
    Beta:1.83
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:51.76 - 52.89
    52wk Range:41.99 - 80.42
    Volume:215,018
    Avg Vol (3m):375,503
    Market Cap:1.04B
    P/E (ttm):157.36
    EPS (ttm):0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 0.21%1.04B
    LLYUp 2.01%76.68B
    MRKUp 1.67%167.03B
    RHHBYUp 2.41%250.80B

    Key Statistics

    Forward P/E (1 yr):22.63
    P/S (ttm):18.52
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-14) :1.53
    Quarterly EPS Est (Dec-14) :0.60
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.73

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback